ஆலோசனை மேலாண்மை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆலோசனை மேலாண்மை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆலோசனை மேலாண்மை Today - Breaking & Trending Today

Мэр Каменского Белоусов дал добро на незаконную застройку МАФами исторического центра города, - СМИ

Мэр Каменского Белоусов дал добро на незаконную застройку МАФами исторического центра города, - СМИ
podrobnosti.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from podrobnosti.ua Daily Mail and Mail on Sunday newspapers.

Dnipropetrovs Ka Oblast , Belousovi Daniel , Belousov Anastasia , Andrew Belousov , Kamensky Belousov , Alexander Smith , Kamensky Julia Saenko , Kamensky The City Council , Mayor Kamensky Belousov , Independence Heroes , Central Highway , City Hall , May National , River Port , City Council , Consulting Management , Itself Anastasia , அலெக்சாண்டர் ஸ்மித் , மைய நெடுஞ்சாலை , நகரம் மண்டபம் , இருக்கலாம் தேசிய , நதி போர்த் , நகரம் சபை , ஆலோசனை மேலாண்மை ,

Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results


Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results
OVERVIEW
The Company reported a net loss and total comprehensive loss of $2,554,000 and $5,268,000 for the three and nine-month periods ended April 30, 2021. For the three and nine-month periods ended April 30, 2020, net loss and total comprehensive loss totalled $2,489,000 and $6,896,000, respectively. The net loss and total comprehensive loss for the three-month period ending April 30, 2021, includes a net loss of $nil (2020 - $198,000) and for the nine-month period ending April 30, 2021 a gain of $1,536,000 (2020 - loss of $465,000) from discontinued operations. The Company lost control of its subsidiary in Poland during the three-month period ending October 31, 2020 though continued to exert significant influence until December 22, 2020 when the Company disposed of its remaining interest for gross proceeds of $2,308,000. ....

Richmond Hill , Frank Michalargias , Pascal Nigen , Helix Biopharma Corp , Company Interim Condensed Statement Of Financial Position , Company Interim Condensed Financial , Fund Management , Moffit Cancer Centre , Alpha Bronze , Company Interim Condensed Statement Of Net Loss , Lind Global Macro Fund , Helix Biopharma , Investigational New Drug , Multijurisdictional Disclosure System , Accounting Oversight Board , Consulting Management , Convertible Security , Interim Condensed Statement , Net Loss , Comprehensive Loss , Condensed Statements , Financial Position , Interim Condensed Financial Statements , Chief Financial , Looking Statements , Annual Information Form ,